What is the address of DR CHIARELLI CYNTHIA - PEDIATRE?

The registered office of DR CHIARELLI CYNTHIA - PEDIATRE is located at Rue Dry Herleux,Han 20, 5580 Rochefort.

Is DR CHIARELLI CYNTHIA - PEDIATRE still active?

Yes. According to the CBE (28 September 2026) DR CHIARELLI CYNTHIA - PEDIATRE is active, legal situation “Normale toestand”, started on 27 February 2018.

Is DR CHIARELLI CYNTHIA - PEDIATRE registered on Peppol?

Yes, DR CHIARELLI CYNTHIA - PEDIATRE is registered on the Peppol network with ID 0208:0691551503.

What is the enterprise number of DR CHIARELLI CYNTHIA - PEDIATRE?

The enterprise number of DR CHIARELLI CYNTHIA - PEDIATRE is BE0691551503.

When was DR CHIARELLI CYNTHIA - PEDIATRE founded?

DR CHIARELLI CYNTHIA - PEDIATRE was founded on 27 February 2018.

Who are the directors of DR CHIARELLI CYNTHIA - PEDIATRE?

According to the 2025 annual accounts, the directors of DR CHIARELLI CYNTHIA - PEDIATRE are: Cynthia CHIARELLI.

Is DR CHIARELLI CYNTHIA - PEDIATRE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 February 2018; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR CHIARELLI CYNTHIA - PEDIATRE make in 2025?

DR CHIARELLI CYNTHIA - PEDIATRE posted a profit after taxes of € 82,621 in financial year 2025.

What is the revenue of DR CHIARELLI CYNTHIA - PEDIATRE?

As a small company, DR CHIARELLI CYNTHIA - PEDIATRE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 219,002.

DR CHIARELLI CYNTHIA - PEDIATRE (Private Limited)

Dossier DR CHIARELLI CYNTHIA - PEDIATRE, printed on 28 September 2026 from databakkes.be/en/0691551503/dr-chiarelli-cynthia-pediatre. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR CHIARELLI CYNTHIA - PEDIATRE from Rochefort, company number BE0691551503, closed financial year 2025 with a result of € 82,621 after tax. For that financial year DR CHIARELLI CYNTHIA - PEDIATRE recorded a gross margin of € 219,002 and equity of € 31,221. Compared with financial year 2024, the result moved from € 85,942 to € 82,621. The company is profitable. The buffer shrank hard: equity is 70 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.

What it is worth Shrank hard

€ 31,221

▼ 70% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 82,621

▼ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 171,094

▲ 58% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 155,942 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 157,180

▼ 12% vs 2024

Of which on lease € 152,599.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 223,919

▼ 6% vs 2024

€ 33,660 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 3,329

▼ 20% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 27,865

▲ € 25,191 vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 202,512 Gross margin 2022: € 202,512 First fiscal year in the series	€ 177,353 Gross margin 2023: € 177,353 ▼ 12% vs 2022 (€ 202,512) Unfavourable step	€ 194,740 Gross margin 2024: € 194,740 ▲ 10% vs 2023 (€ 177,353) Favourable step	€ 219,002 Gross margin 2025: € 219,002 ▲ 12% vs 2024 (€ 194,740) Favourable step	▲ 12%
Profit after taxes	€ 95,530 Profit after taxes 2022: € 95,530 First fiscal year in the series	€ 69,851 Profit after taxes 2023: € 69,851 ▼ 27% vs 2022 (€ 95,530) Unfavourable step	€ 85,942 Profit after taxes 2024: € 85,942 ▲ 23% vs 2023 (€ 69,851) Favourable step	€ 82,621 Profit after taxes 2025: € 82,621 ▼ 4% vs 2024 (€ 85,942) Unfavourable step	▼ 4%
Equity	€ 115,990 Equity 2022: € 115,990 First fiscal year in the series	€ 90,311 Equity 2023: € 90,311 ▼ 22% vs 2022 (€ 115,990) Unfavourable step	€ 104,542 Equity 2024: € 104,542 ▲ 16% vs 2023 (€ 90,311) Favourable step	€ 31,221 Equity 2025: € 31,221 ▼ 70% vs 2024 (€ 104,542) Unfavourable step	▼ 70%
Total debts	€ 360,939 Total debts 2022: € 360,939 First fiscal year in the series	€ 429,326 Total debts 2023: € 429,326 ▲ 19% vs 2022 (€ 360,939) Unfavourable step	€ 321,940 Total debts 2024: € 321,940 ▼ 25% vs 2023 (€ 429,326) Favourable step	€ 409,997 Total debts 2025: € 409,997 ▲ 27% vs 2024 (€ 321,940) Unfavourable step	▲ 27%
Cash	€ 108,677 Cash 2022: € 108,677 First fiscal year in the series	€ 163,099 Cash 2023: € 163,099 ▲ 50% vs 2022 (€ 108,677) Favourable step	€ 108,422 Cash 2024: € 108,422 ▼ 34% vs 2023 (€ 163,099) Unfavourable step	€ 171,094 Cash 2025: € 171,094 ▲ 58% vs 2024 (€ 108,422) Favourable step	▲ 58%
Retained profit	€ 97,390 Retained profit 2022: € 97,390 First fiscal year in the series	€ 71,711 Retained profit 2023: € 71,711 ▼ 26% vs 2022 (€ 97,390) Unfavourable step	€ 85,942 Retained profit 2024: € 85,942 ▲ 20% vs 2023 (€ 71,711) Favourable step	€ 12,621 Retained profit 2025: € 12,621 ▼ 85% vs 2024 (€ 85,942) Unfavourable step	▼ 85%
Dividend	€ 59,994 Dividend 2022: € 59,994 First fiscal year in the series	€ 95,530 Dividend 2023: € 95,530 ▲ 59% vs 2022 (€ 59,994) Unchanged	€ 66,585 Dividend 2024: € 66,585 ▼ 30% vs 2023 (€ 95,530) Unchanged	€ 155,942 Dividend 2025: € 155,942 ▲ 134% vs 2024 (€ 66,585) Unchanged	▲ 134%
Bank debt	€ 272,342 Bank debt 2022: € 272,342 First fiscal year in the series	€ 260,073 Bank debt 2023: € 260,073 ▼ 5% vs 2022 (€ 272,342) Favourable step	€ 238,560 Bank debt 2024: € 238,560 ▼ 8% vs 2023 (€ 260,073) Favourable step	€ 223,919 Bank debt 2025: € 223,919 ▼ 6% vs 2024 (€ 238,560) Favourable step	▼ 6%
Balance sheet total	€ 476,929 Balance sheet total 2022: € 476,929 First fiscal year in the series	€ 519,638 Balance sheet total 2023: € 519,638 ▲ 9% vs 2022 (€ 476,929) Unchanged	€ 426,481 Balance sheet total 2024: € 426,481 ▼ 18% vs 2023 (€ 519,638) Unchanged	€ 441,219 Balance sheet total 2025: € 441,219 ▲ 3% vs 2024 (€ 426,481) Unchanged	▲ 3%

Key figures of DR CHIARELLI CYNTHIA - PEDIATRE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR CHIARELLI CYNTHIA - PEDIATRE?

What happened at DR CHIARELLI CYNTHIA - PEDIATRE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 27, 2026 New annual accounts for financial year 2025: profit of € 82,621 (▼ 4% vs 2024). Source: NBB ↗
Feb 27, 2018 New establishment in Rochefort. KBO
Feb 27, 2018 Start of the company according to the CBE. KBO
2018 Cynthia CHIARELLI became a director. NBB

In short

From € 95,530 profit in 2022 to € 82,621 profit in 2025.

Paid € 109,388 in corporate taxes since 2022.

Best year ever: 2022, with € 95,530 profit.

Paid out € 378,051 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR CHIARELLI CYNTHIA - PEDIATRE? We notify you, reason included.

Follow DR CHIARELLI CYNTHIA - PEDIATRE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Cynthia CHIARELLI

DR CHIARELLI CYNTHIA - PEDIATRE

Behind DR CHIARELLI CYNTHIA - PEDIATRE is Cynthia CHIARELLI.

See the full network in the app

Directors

According to the 2025 annual accounts

Cynthia CHIARELLI

Director

since 2018

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Dry Herleux,Han 20

5580 Rochefort

2.273.845.591

Rue des Grottes,Han 62

5580 Rochefort

Active since 27 February 2018

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0691.551.503
VAT number: BE 0691.551.503
Registered office: Rue Dry Herleux,Han 20, 5580 Rochefort
Names & denominations: DR CHIARELLI CYNTHIA - PEDIATRE · CHIARELLI CYNTHIA
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 27 February 2018
Peppol: Active · Active since 11 Mar 2026

View on CBE Public ↗ Annual accounts (NBB) ↗